CCR5 and breast cancer: In recent years, an increasing number of studies have shown that in tumor tissues, the high expression level of CCR5 can be used as a biological indicator of poor prognosis of colorectal cancer, prostate cancer, and breast cancer, and has the potential to be introduced to evaluate tumor invasion and metastasis.24, 25